To elucidate the relevance of genetic alterations, we analysed 17 genes known to be involved in haematological neoplasms in patients with chronic leucocytosis and patients with persistent thrombocytosis. Mutations of the , and genes were found in 1/13, 1/13, and 2/13 patients with leucocytosis, respectively. Mutations of the , , and genes were found in 1/5, 1/5, 1/5 and 2/5 patients with thrombocytosis, respectively.
View Article and Find Full Text PDFObjectives: We previously reported loss of heterozygosity on 1p in chronic myelogenous leukemia (CML). We analyzed promoter methylation and mutation of tumor suppressor genes on 1p36 in CML.
Methods: We performed methylation-specific PCR (MS-PCR) analysis of the PRDM2, RUNX3, and TP73 genes in 61 patients with CML (43 chronic phase, CP; two accelerated phase; and 16 blast crisis, BC).